Sanofi pays Scribe $25M to access CRISPR tools, writing new chapter in its NK cell therapy story
Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer
Starting a Revolution Isn’t Enough
Memora Health Announces Partnership with UP Medical to Reduce Care Team Burden and Engage Patients Outside of Clinic Walls
10 years on, a spin-off use for CRISPR: Infectious disease testing
Revolutionary Crispr Gene Editing Speeds from Lab to Treatment Room
Her Discovery Changed the World. How Does She Think We Should Use It?
CEO of Doudna spinout: Within five years, genome editors will have a ‘really big impact’ on patients’ lives
Cartography Biosciences Launches to Accelerate Precision Immunotherapy with Comprehensive Antigen Profiling
How Jennifer Doudna’s Life Has Changed Since Discovering CRISPR 10 Years Ago
CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissors’ first decade
As Crispr Turns 10, Its Medical Promise Comes Into Focus
CRISPR, 10 Years On: Learning to Rewrite the Code of Life
Supercharging Plants and Soils to Remove Carbon from the Atmosphere
LatchBio Raises $28M Series A to Bring a Modern Data Analysis Stack to Biologists
The TIME 100 Most Influential People of 2022
Noyo Raises $45M in Series B Financing to Accelerate the Delivery of Frictionless Employee Benefits Experiences
Concert Health Raises $42M Series B Financing to Scale Quality Behavioral Health Services Nationwide
Future of CRISPR Technology
The Hard Lessons We Learned — and Didn’t — From Two Years in Pandemic School
Memora Health Announces $40M Financing To Scale Platform for Simplifying Complex Care Delivery
CRISPR Co-inventor Jennifer Doudna on Future of Biotech
Many of our proteins remain hidden in the dark proteome
Reshaping Evolution
3 CRISPR editing innovations to watch in 2022
Researchers See a New Path to Curbing Methane in Rice
First sickle cell patient treated with CRISPR gene-editing still thriving
These gene-editing startups are aiming to solve one of CRISPR’s biggest problems. Here’s how they could upend biotech in 2022.
Why 2022 is a make-it or break-it year for CRISPR
C&EN’s 2021 10 Start-Ups to Watch
How To Maximize Non-Emergency Medical Transportation’s Potential To Address Social Determinants Of Health
Andreessen Horowitz Leads $22M in Funding for Thyme Care to Improve Patient Outcomes, Close Gaps in Health Disparities, and Drive Value-Based Cancer Care
CRISPR: A guide to the health revolution that will define the 21st century
A startup delivers mental health care to those missed by the unicorns
Meet the 30 young leaders forging a new future for the healthcare industry in 2021
Genetic Dreams, Genetic Nightmares
Meet the 12 biotechs pioneering cutting-edge cures that stand to upend how we treat diseases and transform pharma
Newly-Discovered ‘Borg’ DNA Is Unlike Anything Scientists Have Ever Seen
Crispr gene-editing ‘revolution’ treats internal organ for first time
He Inherited A Devastating Disease. A CRISPR Gene-Editing Breakthrough Stopped It
CRISPR injected into the blood treats a genetic disease for first time
New Technology Could Unlock The Secrets Of Every Protein In The Body
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
Concert Health Inks Two More Collaborative Care Partnerships, Continues Aggressive Growth
Recursion CSO heads west for mini-brain upstart
A View From The Top: Six Healthcare Execs On How To Close The Nation’s Mental Health Care Gap
NFT for Nobel Prize-Winning Data to Be Auctioned by UC Berkeley
Renowned ‘Drug Hunter’ Joins Team To Cure Challenging Brain Diseases
You Can Buy a Piece of a Nobel Prize-Winning Discovery
Herophilus Appoints Sharath Hegde, Ph.D. as Chief Scientific Officer as it Scales Drug Discovery Effort for Complex Brain Diseases
Star Trek-style scanner creates ‘digital twin’ to track your health
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists
Doudna and Arnold Chat “Nobel to Nobel”
Meet Dr. Jennifer Doudna: She’s Leading the Biotech Revolution
Q Bio unveils ‘digital twin’ whole-body imaging platform, with Kaiser Permanente backing
Bloomberg Studio 1.0: CRISPR Co-Inventor Dr. Jennifer Doudna
The 20(+1) under 40: Inside the next generation of biotech leaders
Scribe Therapeutics snags $100M for engineered CRISPR tech, pipeline
Doudna’s Scribe Rewrites CRISPR Drug Development with $100 Million Series B
Scribe, Jennifer Doudna’s newest startup, nabs a mega-round and a vocal investor
